Cargando…
High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.
Autores principales: | Yeh, K. H., Cheng, A. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063385/ https://www.ncbi.nlm.nih.gov/pubmed/9020500 |
Ejemplares similares
-
Encephalopathy, lactic acidosis, hyperammonaemia and 5-fluorouracil toxicity.
por: Valik, D.
Publicado: (1998) -
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.
por: O'Byrne, K. J., et al.
Publicado: (1998) -
Acute Cardiogenic Shock Induced by Infusional 5-Fluorouracil
por: Sulpher, Jeffrey, et al.
Publicado: (2014) -
Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?
por: Rosen, A., et al.
Publicado: (2011) -
Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
por: Gonzalez, M A, et al.
Publicado: (2003)